JPS538034A
(en)
*
|
1976-06-30 |
1978-01-25 |
Toshiba Corp |
Electronic computer
|
US4297559A
(en)
*
|
1979-05-10 |
1981-10-27 |
Olin Corporation |
Apparatus for controlled perforation of moving webs with fixed focus laser beam
|
US4380855A
(en)
*
|
1980-01-18 |
1983-04-26 |
University Of Rochester |
Method for filling hollow shells with gas for use as laser fusion targets
|
GB2073639A
(en)
*
|
1980-02-20 |
1981-10-21 |
Duracell Int |
Apparatus and method for spot heat treating workpieces
|
US4265874A
(en)
*
|
1980-04-25 |
1981-05-05 |
Alza Corporation |
Method of delivering drug with aid of effervescent activity generated in environment of use
|
US4344929A
(en)
*
|
1980-04-25 |
1982-08-17 |
Alza Corporation |
Method of delivering drug with aid of effervescent activity generated in environment of use
|
US4439195A
(en)
*
|
1980-10-14 |
1984-03-27 |
Alza Corporation |
Theophylline therapy
|
US4484921A
(en)
*
|
1982-02-01 |
1984-11-27 |
Alza Corporation |
Theophylline therapy utilizing osmotic delivery
|
US4539060A
(en)
*
|
1983-02-18 |
1985-09-03 |
Warner-Lambert Company |
Apparatus and method of sealing capsules
|
US4503030A
(en)
*
|
1983-06-06 |
1985-03-05 |
Alza Corporation |
Device for delivering drug to certain pH environments
|
US4927633A
(en)
*
|
1984-03-19 |
1990-05-22 |
Alza Corporation |
Dispenser for delivering drug to livestock
|
US4684524A
(en)
*
|
1984-03-19 |
1987-08-04 |
Alza Corporation |
Rate controlled dispenser for administering beneficial agent
|
US4844984A
(en)
*
|
1984-03-19 |
1989-07-04 |
Alza Corporation |
Dispensing system with means for increasing delivery of beneficial agent from the system
|
US5000957A
(en)
*
|
1984-03-19 |
1991-03-19 |
Alza Corporation |
Dispenser comprising hydrophilic osmopolymer
|
US4692336A
(en)
*
|
1984-03-19 |
1987-09-08 |
Alza Corporation |
Self controlled release device for administering beneficial agent to recipient
|
US4624945A
(en)
*
|
1984-03-19 |
1986-11-25 |
Alza Corporation |
Dispensing system with means for increasing delivery of beneficial agent from the system
|
US4612186A
(en)
*
|
1984-03-19 |
1986-09-16 |
Alza Corporation |
Method for establishing blood levels of biocide in animals
|
US4717566A
(en)
*
|
1984-03-19 |
1988-01-05 |
Alza Corporation |
Dosage system and method of using same
|
US4595583A
(en)
*
|
1984-03-19 |
1986-06-17 |
Alza Corporation |
Delivery system controlled administration of beneficial agent to ruminants
|
US4729793A
(en)
*
|
1985-08-09 |
1988-03-08 |
Alza Corporation |
Composition for manufacturing wall of dispensing device
|
US4693886A
(en)
*
|
1985-04-22 |
1987-09-15 |
Alza Corporation |
Osmotic device with inert core
|
US4627971A
(en)
*
|
1985-04-22 |
1986-12-09 |
Alza Corporation |
Osmotic device with self-sealing passageway
|
US4717718A
(en)
*
|
1985-08-09 |
1988-01-05 |
Alza Corporation |
Device for the controlled delivery of a beneficial agent
|
US4717568A
(en)
*
|
1985-08-09 |
1988-01-05 |
Alza Corporation |
Laminar arrangement for increasing delivery of beneficial agent from dispenser
|
US4966767A
(en)
*
|
1985-08-16 |
1990-10-30 |
Alza Corporation |
Ruminant dispensing device comprising agent displacement member
|
US4675174A
(en)
*
|
1985-08-16 |
1987-06-23 |
Alza Corporation |
Veterinary dispenser delivering beneficial agent by gas power generated in situ
|
US4643731A
(en)
*
|
1985-08-16 |
1987-02-17 |
Alza Corporation |
Means for providing instant agent from agent dispensing system
|
US4865598A
(en)
*
|
1985-08-16 |
1989-09-12 |
Alza Corporation |
Dispensing system for administering beneficial agent
|
US4883667A
(en)
*
|
1985-08-16 |
1989-11-28 |
Alza Corporation |
Process for forming dispensing device
|
US4704118A
(en)
*
|
1985-08-16 |
1987-11-03 |
Alza Corporation |
Ruminant dispensing device with thermo-activated memory
|
US4871544A
(en)
*
|
1985-08-16 |
1989-10-03 |
Alza Corporation |
Ruminant dispensing device
|
US4963141A
(en)
*
|
1985-08-16 |
1990-10-16 |
Alza Corporation |
Dispensing system for administering beneficial agent formulation to ruminants
|
US5098425A
(en)
*
|
1985-08-16 |
1992-03-24 |
Alza Corporation |
Method of administering a ruminant dispensing device comprising density member dispersed in hydrogel member
|
US4955881A
(en)
*
|
1985-08-16 |
1990-09-11 |
Alza Corporation |
Ruminant dispensing device
|
US4801461A
(en)
*
|
1987-01-28 |
1989-01-31 |
Alza Corporation |
Pseudoephedrine dosage form
|
US4915952A
(en)
*
|
1987-02-27 |
1990-04-10 |
Alza Corporation |
Composition comprising drug, HPC, HPMC and PEO
|
US5023076A
(en)
*
|
1987-02-27 |
1991-06-11 |
Alza Corporation |
Lamina comprising carboxyvinyl polymer
|
US4950486A
(en)
*
|
1987-10-02 |
1990-08-21 |
Alza Corporation |
Dosage form for treating cardiovascular diseases
|
US4946687A
(en)
*
|
1987-10-02 |
1990-08-07 |
Alza Corporation |
Dosage form for treating cardiovascular diseases
|
US4816263A
(en)
*
|
1987-10-02 |
1989-03-28 |
Alza Corporation |
Dosage form for treating cardiovascular diseases comprising isradipine
|
US4996060A
(en)
*
|
1988-03-25 |
1991-02-26 |
Alza Corporation |
Device comprising liner for protecting fluid sensitive medicament
|
US4959218A
(en)
*
|
1988-03-25 |
1990-09-25 |
Alza Corporation |
Method for delivering somatotropin to an animal
|
US4855141A
(en)
*
|
1988-03-25 |
1989-08-08 |
Alza Corporation |
Device comprising means for protecting and dispensing fluid sensitive medicament
|
US5019397A
(en)
*
|
1988-04-21 |
1991-05-28 |
Alza Corporation |
Aqueous emulsion for pharmaceutical dosage form
|
US5160743A
(en)
*
|
1988-04-28 |
1992-11-03 |
Alza Corporation |
Annealed composition for pharmaceutically acceptable drug
|
US5024842A
(en)
*
|
1988-04-28 |
1991-06-18 |
Alza Corporation |
Annealed coats
|
US4931285A
(en)
*
|
1988-04-28 |
1990-06-05 |
Alza Corporation |
Aqueous based pharmaceutical coating composition for dosage forms
|
US5006346A
(en)
*
|
1988-04-28 |
1991-04-09 |
Alza Corporation |
Delivery system
|
US4966769A
(en)
*
|
1988-06-02 |
1990-10-30 |
Alza Corporation |
Method for delivering dosage form for diltiazem
|
US4859470A
(en)
*
|
1988-06-02 |
1989-08-22 |
Alza Corporation |
Dosage form for delivering diltiazem
|
US4873414A
(en)
*
|
1988-06-13 |
1989-10-10 |
Rolls Royce Inc. |
Laser drilling of components
|
US4896944A
(en)
*
|
1988-07-25 |
1990-01-30 |
Irwin Timothy L |
Method and apparatus for trepanning workpieces
|
US5096716A
(en)
*
|
1988-09-01 |
1992-03-17 |
Alza Corporation |
Dosage form for administering calcium antagonist nicardipine
|
US5030456A
(en)
*
|
1988-11-07 |
1991-07-09 |
Alza Corporation |
Dosage form for treating cardiovascular diseases
|
US5110596A
(en)
*
|
1988-12-13 |
1992-05-05 |
Alza Corporation |
Delivery system comprising means for delivering agent to livestock
|
US5034229A
(en)
*
|
1988-12-13 |
1991-07-23 |
Alza Corporation |
Dispenser for increasing feed conversion of hog
|
US5059423A
(en)
*
|
1988-12-13 |
1991-10-22 |
Alza Corporation |
Delivery system comprising biocompatible beneficial agent formulation
|
US5728088A
(en)
*
|
1988-12-13 |
1998-03-17 |
Alza Corporation |
Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals
|
US5037420A
(en)
*
|
1988-12-13 |
1991-08-06 |
Alza Corporation |
Delivery system comprising two sections for delivering somatotropin
|
US5174999A
(en)
*
|
1988-12-13 |
1992-12-29 |
Alza Corporation |
Delivery system comprising fluid ingress and drug egress
|
US5135523A
(en)
*
|
1988-12-13 |
1992-08-04 |
Alza Corporation |
Delivery system for administering agent to ruminants and swine
|
US5057318A
(en)
*
|
1988-12-13 |
1991-10-15 |
Alza Corporation |
Delivery system for beneficial agent over a broad range of rates
|
US5186942A
(en)
*
|
1989-01-30 |
1993-02-16 |
Alza Corporation |
Nicardipine therapy
|
US5019396A
(en)
*
|
1989-05-12 |
1991-05-28 |
Alza Corporation |
Delivery dispenser for treating cardiac arrhythmias
|
US5063280A
(en)
*
|
1989-07-24 |
1991-11-05 |
Canon Kabushiki Kaisha |
Method and apparatus for forming holes into printed circuit board
|
US5091190A
(en)
*
|
1989-09-05 |
1992-02-25 |
Alza Corporation |
Delivery system for administration blood-glucose lowering drug
|
US5024843A
(en)
*
|
1989-09-05 |
1991-06-18 |
Alza Corporation |
Oral hypoglycemic glipizide granulation
|
US20020197309A1
(en)
*
|
1989-09-05 |
2002-12-26 |
Kuczynski Anthony L. |
Method for lowering blood glucose
|
US5591454A
(en)
*
|
1989-09-05 |
1997-01-07 |
Alza Corporation |
Method for lowering blood glucose
|
US5035897A
(en)
*
|
1989-09-05 |
1991-07-30 |
Alza Corporation |
Dosage form for delivering soluble or insoluble drugs
|
US6361795B1
(en)
|
1989-09-05 |
2002-03-26 |
Alza Corporation |
Method for lowering blood glucose
|
US5112614A
(en)
*
|
1989-09-14 |
1992-05-12 |
Alza Corporation |
Implantable delivery dispenser
|
US5098714A
(en)
*
|
1989-11-16 |
1992-03-24 |
Alza Corporation |
Osmotic, oral dosage form for fertility control
|
US5200197A
(en)
*
|
1989-11-16 |
1993-04-06 |
Alza Corporation |
Contraceptive pill
|
US5071607A
(en)
*
|
1990-01-31 |
1991-12-10 |
Alza Corporatino |
Method and apparatus for forming a hole in a drug dispensing device
|
US5234692A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5234694A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Method for increasing feed efficiency in animals
|
US5234693A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5180591A
(en)
*
|
1990-07-11 |
1993-01-19 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5238687A
(en)
*
|
1990-07-11 |
1993-08-24 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5166145A
(en)
*
|
1990-09-10 |
1992-11-24 |
Alza Corporation |
Antiemetic therapy
|
JPH0460918U
(US06331856-20011218-P00008.png)
*
|
1990-09-29 |
1992-05-26 |
|
|
EP0495647B1
(en)
*
|
1991-01-17 |
1997-05-02 |
United Distillers Plc |
Dynamic laser marking
|
US5443459A
(en)
*
|
1991-01-30 |
1995-08-22 |
Alza Corporation |
Osmotic device for delayed delivery of agent
|
US5861166A
(en)
*
|
1991-03-12 |
1999-01-19 |
Alza Corporation |
Delivery device providing beneficial agent stability
|
JPH04121915U
(ja)
*
|
1991-04-09 |
1992-10-30 |
株式会社椿本チエイン |
オーバーヘツドコンベヤの搬送物保護構造
|
US5198229A
(en)
*
|
1991-06-05 |
1993-03-30 |
Alza Corporation |
Self-retaining gastrointestinal delivery device
|
US5137727A
(en)
*
|
1991-06-12 |
1992-08-11 |
Alza Corporation |
Delivery device providing beneficial agent stability
|
US6764697B1
(en)
|
1991-06-27 |
2004-07-20 |
Alza Corporation |
System for delaying drug delivery up to seven hours
|
US5178867A
(en)
*
|
1991-08-19 |
1993-01-12 |
Alza Corporation |
Dosage form for delivering drug in short-time period
|
US5266331A
(en)
*
|
1991-11-27 |
1993-11-30 |
Euroceltique, S.A. |
Controlled release oxycodone compositions
|
US5478577A
(en)
*
|
1993-11-23 |
1995-12-26 |
Euroceltique, S.A. |
Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
|
US5223265A
(en)
*
|
1992-01-10 |
1993-06-29 |
Alza Corporation |
Osmotic device with delayed activation of drug delivery
|
US5294770A
(en)
*
|
1992-01-14 |
1994-03-15 |
Alza Corporation |
Laser tablet treatment system with dual access to tablet
|
US5246711A
(en)
*
|
1992-02-27 |
1993-09-21 |
Alza Corporation |
Dosage form for treating dysthymia
|
US5185158A
(en)
*
|
1992-02-27 |
1993-02-09 |
Alza Corporation |
Dosage form comprising succinimide drug for treating depressive disorders and composition comprising same
|
US5858407A
(en)
*
|
1992-02-27 |
1999-01-12 |
Alza Corporation |
Method for administering tandospirone
|
US5330762A
(en)
*
|
1992-02-27 |
1994-07-19 |
Alza Corporation |
Tandospiaine antidepressive therapy
|
US5246710A
(en)
*
|
1992-02-27 |
1993-09-21 |
Alza Corporation |
Dosage form for treating cyclothymia
|
US5688518A
(en)
*
|
1992-02-27 |
1997-11-18 |
Alza Corporation |
Antidepressive therapy
|
US5376771A
(en)
*
|
1992-07-07 |
1994-12-27 |
Merck & Co., Inc. |
High speed process for preparing orifices in pharmaceutical dosage forms
|
US20080075781A1
(en)
*
|
1992-11-25 |
2008-03-27 |
Purdue Pharma Lp |
Controlled release oxycodone compositions
|
US5358721A
(en)
*
|
1992-12-04 |
1994-10-25 |
Alza Corporation |
Antiviral therapy
|
IL119660A
(en)
*
|
1993-05-10 |
2002-09-12 |
Euro Celtique Sa |
Controlled release formulation comprising tramadol
|
US6440457B1
(en)
|
1993-05-27 |
2002-08-27 |
Alza Corporation |
Method of administering antidepressant dosage form
|
US6287598B1
(en)
*
|
1993-05-28 |
2001-09-11 |
Alza Corporation |
Method for providing sustained antiepileptic therapy
|
US20070275062A1
(en)
*
|
1993-06-18 |
2007-11-29 |
Benjamin Oshlack |
Controlled release oxycodone compositions
|
IL110014A
(en)
*
|
1993-07-01 |
1999-11-30 |
Euro Celtique Sa |
Solid controlled-release oral dosage forms of opioid analgesics
|
US7740881B1
(en)
|
1993-07-01 |
2010-06-22 |
Purdue Pharma Lp |
Method of treating humans with opioid formulations having extended controlled release
|
US5879705A
(en)
*
|
1993-07-27 |
1999-03-09 |
Euro-Celtique S.A. |
Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
|
US5532003A
(en)
*
|
1994-01-18 |
1996-07-02 |
Alza Corporation |
Pentoxifylline therapy
|
US20040191314A1
(en)
*
|
1994-04-28 |
2004-09-30 |
Frank Jao |
Antiepileptic dosage form and process for protecting antiepileptic drug
|
ZA953078B
(en)
*
|
1994-04-28 |
1996-01-05 |
Alza Corp |
Effective therapy for epilepsies
|
US5411745A
(en)
*
|
1994-05-25 |
1995-05-02 |
Euro-Celtique, S.A. |
Powder-layered morphine sulfate formulations
|
US6077533A
(en)
*
|
1994-05-25 |
2000-06-20 |
Purdue Pharma L.P. |
Powder-layered oral dosage forms
|
US5698224A
(en)
*
|
1994-06-27 |
1997-12-16 |
Alza Corporation |
Tacrine therapy
|
US5914131A
(en)
*
|
1994-07-07 |
1999-06-22 |
Alza Corporation |
Hydromorphone therapy
|
US5633011A
(en)
*
|
1994-08-04 |
1997-05-27 |
Alza Corporation |
Progesterone replacement therapy
|
US5718700A
(en)
*
|
1994-09-20 |
1998-02-17 |
Alza Corporation |
Exit means in dosage form
|
GB9422154D0
(en)
*
|
1994-11-03 |
1994-12-21 |
Euro Celtique Sa |
Pharmaceutical compositions and method of producing the same
|
US5595759A
(en)
*
|
1994-11-10 |
1997-01-21 |
Alza Corporation |
Process for providing therapeutic composition
|
US5658474A
(en)
*
|
1994-12-16 |
1997-08-19 |
Alza Corporation |
Method and apparatus for forming dispenser delivery ports
|
US5912268A
(en)
*
|
1995-05-22 |
1999-06-15 |
Alza Corporation |
Dosage form and method for treating incontinence
|
US6262115B1
(en)
|
1995-05-22 |
2001-07-17 |
Alza Coporation |
Method for the management of incontinence
|
US5674895A
(en)
*
|
1995-05-22 |
1997-10-07 |
Alza Corporation |
Dosage form comprising oxybutynin
|
US6124355A
(en)
*
|
1995-05-22 |
2000-09-26 |
Guittard; George V. |
Oxybutynin therapy
|
US20060280774A1
(en)
*
|
1995-06-02 |
2006-12-14 |
Allergan, Inc. |
Compositions and methods for treating glaucoma
|
US5869079A
(en)
*
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
US5690952A
(en)
*
|
1995-06-07 |
1997-11-25 |
Judy A. Magruder et al. |
Implantable system for delivery of fluid-sensitive agents to animals
|
US5783793A
(en)
*
|
1996-02-29 |
1998-07-21 |
Merck & Co., Inc. |
Process for producing a plurality of holes in dosage forms using a laser beam deflected by an acousto-optic deflector
|
ES2255105T3
(es)
*
|
1996-02-29 |
2006-06-16 |
MERCK & CO., INC. |
Proceso de perforacion por laser para producir una pluralidad de orificios en formas de productos quimicos utilizando un deflector acustooptico.
|
JP3220166B2
(ja)
|
1996-05-24 |
2001-10-22 |
アルザ コーポレイション |
栄養サポートシステム
|
US6919373B1
(en)
*
|
1996-11-12 |
2005-07-19 |
Alza Corporation |
Methods and devices for providing prolonged drug therapy
|
US6190351B1
(en)
|
1997-02-28 |
2001-02-20 |
Alza Corporation |
Nutritional support system
|
US6110499A
(en)
*
|
1997-07-24 |
2000-08-29 |
Alza Corporation |
Phenytoin therapy
|
US6514530B2
(en)
|
1997-09-09 |
2003-02-04 |
Alza Corporation |
Dosage form comprising means for changing drug delivery shape
|
US7060734B1
(en)
|
1997-09-09 |
2006-06-13 |
Alza Corporation |
Pharmaceutical coating composition and method of use
|
ATE282407T1
(de)
*
|
1997-09-09 |
2004-12-15 |
Alza Corp |
Arzneimittel-überzugszubereitung und verfahren zu ihrer anwendung
|
US20040062799A1
(en)
*
|
1997-09-29 |
2004-04-01 |
Ayer Atul D. |
Therapeutic composition and delivery system for administering drug
|
ES2172944T3
(es)
|
1997-12-05 |
2002-10-01 |
Alza Corp |
Forma de dosificacion osmotica que comprende un primer y un segundo revestimiento.
|
US20060141036A1
(en)
*
|
1997-12-12 |
2006-06-29 |
Andrx Labs Llc |
HMG-CoA reductase inhibitor extended release formulation
|
TR200001828T2
(tr)
*
|
1997-12-22 |
2000-11-21 |
Euro-Celtique, S.A. |
Opioid dozaj şekillerinin kötüye kullanımını önlemeye yönelik bir yöntem.
|
US6375957B1
(en)
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
SI1685839T1
(sl)
|
1997-12-22 |
2013-08-30 |
Euro-Celtique S.A. |
Farmacevtska oralna dozirna oblika, ki vsebuje kombinacijo opioidnega agonista in opioidnega antagonista
|
US6245357B1
(en)
|
1998-03-06 |
2001-06-12 |
Alza Corporation |
Extended release dosage form
|
US8524277B2
(en)
*
|
1998-03-06 |
2013-09-03 |
Alza Corporation |
Extended release dosage form
|
US6099859A
(en)
*
|
1998-03-20 |
2000-08-08 |
Andrx Pharmaceuticals, Inc. |
Controlled release oral tablet having a unitary core
|
AR018321A1
(es)
*
|
1998-03-26 |
2001-11-14 |
Alza Corp |
Una forma de dosificacion de liberacion prolongada que comprende oxibutinina y los usos de la oxibutinina y de la forma de dosificacion de liberacionprolongada.
|
US20010038855A1
(en)
*
|
1998-06-05 |
2001-11-08 |
Desjardin Michael A. |
Dosage form for administering prescribed dose
|
TW407058B
(en)
|
1998-07-17 |
2000-10-01 |
Dev Center Biotechnology |
Oral cisapride dosage forms with an extended duration
|
US6806294B2
(en)
|
1998-10-15 |
2004-10-19 |
Euro-Celtique S.A. |
Opioid analgesic
|
AU1238500A
(en)
|
1998-11-02 |
2000-05-22 |
Alza Corporation |
Controlled delivery of active agents
|
US6706282B1
(en)
|
1998-11-02 |
2004-03-16 |
Evangeline Cruz |
Controlled delivery of phenoxyethyl-substituted 1,2,4-triazolones
|
US6342249B1
(en)
|
1998-12-23 |
2002-01-29 |
Alza Corporation |
Controlled release liquid active agent formulation dosage forms
|
US6452133B1
(en)
|
1999-07-26 |
2002-09-17 |
Alza Corporation |
Apparatus and methods for alternating laser treatment of pharmaceutical dispensers
|
US6331313B1
(en)
|
1999-10-22 |
2001-12-18 |
Oculex Pharmaceticals, Inc. |
Controlled-release biocompatible ocular drug delivery implant devices and methods
|
ES2374717T3
(es)
|
1999-10-29 |
2012-02-21 |
Euro-Celtique S.A. |
Formulaciones de hidrocodona de liberación controlada.
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
WO2001038036A1
(de)
*
|
1999-11-29 |
2001-05-31 |
Siemens Production And Logistics Systems Ag |
Verfahren und vorrichtung zum bearbeiten von substraten mittels laserstrahlen
|
WO2001043721A2
(en)
*
|
1999-12-16 |
2001-06-21 |
Alza Corporation |
Dosage forms having a barrier layer to laser ablation
|
NZ520554A
(en)
|
2000-02-08 |
2005-08-26 |
Euro Celtique S |
Tamper-resistant oral opioid agonist formulations
|
PL357158A1
(en)
|
2000-02-08 |
2004-07-12 |
Euro-Celtique, S.A. |
Controlled-release compositions containing opioid agonist and antagonist
|
GB0003260D0
(en)
*
|
2000-02-11 |
2000-04-05 |
Weston Medical Ltd |
A method of forming a drug capsule for a needlefree injector
|
US6791592B2
(en)
|
2000-04-18 |
2004-09-14 |
Laserink |
Printing a code on a product
|
EP1151673A3
(en)
*
|
2000-05-03 |
2002-01-02 |
Societe Des Produits Nestle S.A. |
Confectionery product having a filling
|
US6726918B1
(en)
|
2000-07-05 |
2004-04-27 |
Oculex Pharmaceuticals, Inc. |
Methods for treating inflammation-mediated conditions of the eye
|
JP2004512354A
(ja)
|
2000-10-30 |
2004-04-22 |
ユーロ−セルティーク,エス.エイ. |
ヒドロコドン放出制御製剤
|
US6790459B1
(en)
|
2000-11-03 |
2004-09-14 |
Andrx Labs, Llc |
Methods for treating diabetes via administration of controlled release metformin
|
MXPA03003994A
(es)
|
2000-11-03 |
2004-09-10 |
Andrx Labs Llc |
Composiciones de metformina de liberacion controlada.
|
US20060034922A1
(en)
*
|
2000-11-03 |
2006-02-16 |
Andrx Labs, Llc |
Controlled release metformin compositions
|
US6866866B1
(en)
*
|
2000-11-03 |
2005-03-15 |
Andrx Labs, Llc |
Controlled release metformin compositions
|
BR0115772A
(pt)
|
2000-11-29 |
2004-01-13 |
Oculex Pharm Inc |
Processos para a redução ou para a prevenção da rejeição ao transplante ocular e de implantes intraoculares para uso para o mesmo
|
JP2002234417A
(ja)
*
|
2000-12-04 |
2002-08-20 |
Takata Corp |
シートベルト巻き取り装置
|
UA81224C2
(uk)
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
CN1525851A
(zh)
|
2001-05-11 |
2004-09-01 |
������ҩ������˾ |
抗滥用阿片样物质控释剂型
|
US7569794B2
(en)
*
|
2001-05-23 |
2009-08-04 |
Osmotica Corp. |
Laser drilling system and method
|
US6809288B2
(en)
*
|
2001-05-23 |
2004-10-26 |
Osmotica Corp. |
Laser drilling system and method
|
ES2296956T5
(es)
*
|
2001-06-11 |
2011-07-12 |
Xenoport, Inc. |
Profármacos de análogos de gaba, composiciones y sus usos.
|
US8048917B2
(en)
|
2005-04-06 |
2011-11-01 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
US7232924B2
(en)
*
|
2001-06-11 |
2007-06-19 |
Xenoport, Inc. |
Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
|
EP1412324A4
(en)
*
|
2001-06-11 |
2004-09-29 |
Xenoport Inc |
AMINO ACID CONJUGATES THAT RESULT IN GABA ANALOGA LASTING SYSTEMIC CONCENTRATIONS
|
US20030044458A1
(en)
*
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
DE60232417D1
(de)
|
2001-08-06 |
2009-07-02 |
Euro Celtique Sa |
Opioid-agonist-formulierungen mit freisetzbarem und sequestriertem antagonist
|
US20030157168A1
(en)
*
|
2001-08-06 |
2003-08-21 |
Christopher Breder |
Sequestered antagonist formulations
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
US6828049B2
(en)
|
2001-10-29 |
2004-12-07 |
Hewlett-Packard Development Company, L.P. |
Replaceable fuel cell apparatus having information storage device
|
US6756564B2
(en)
*
|
2001-12-31 |
2004-06-29 |
Andrx Pharmaceuticals Llc |
System and method for removing particulate created from a drilled or cut surface
|
CN1638743B
(zh)
*
|
2002-03-11 |
2012-11-07 |
爱尔康公司 |
可植入药物的释放系统
|
ITMI20020514A1
(it)
*
|
2002-03-12 |
2003-09-12 |
Jagotec Ag |
Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi
|
ITMI20020515A1
(it)
*
|
2002-03-12 |
2003-09-12 |
Jagotec Ag |
Sistema per il rilasco controllato di uno o piu' principi attivi
|
AU2003224794A1
(en)
*
|
2002-03-29 |
2003-10-13 |
Alza Corporation |
Volume efficient controlled release dosage form
|
KR20040098050A
(ko)
|
2002-04-05 |
2004-11-18 |
유로-셀띠끄 소시에떼 아노님 |
옥시코돈 및 날록손을 포함하는 약제학적 제제
|
US20050106249A1
(en)
*
|
2002-04-29 |
2005-05-19 |
Stephen Hwang |
Once-a-day, oral, controlled-release, oxycodone dosage forms
|
WO2003099214A2
(en)
*
|
2002-05-23 |
2003-12-04 |
Andrx Corporation |
Biguanide formulations
|
AR039744A1
(es)
*
|
2002-06-26 |
2005-03-09 |
Alza Corp |
Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
|
MXPA05000912A
(es)
*
|
2002-07-24 |
2005-03-23 |
Pfizer Prod Inc |
Sistema farmaceutico de perforacion por laser con medios para verificar la orientacion correcta de cada dosificacion.
|
CA2494233A1
(en)
*
|
2002-07-29 |
2004-02-05 |
Alza Corporation |
Formulations and dosage forms for controlled delivery of topiramate
|
US20050232995A1
(en)
*
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
EP1894562B1
(en)
|
2002-08-15 |
2010-12-15 |
Euro-Celtique S.A. |
Pharmaceutical compositions comprising an opioid antagonist
|
US20040132806A1
(en)
|
2002-09-03 |
2004-07-08 |
Jackie Butler |
Pravastatin pharmaceutical formulations and methods of their use
|
PT1551372T
(pt)
*
|
2002-09-20 |
2018-07-23 |
Alpharma Pharmaceuticals Llc |
Subunidade de sequestração e composições e métodos relacionados
|
AU2003293423A1
(en)
|
2002-12-06 |
2004-06-30 |
Xenoport, Inc. |
Carbidopa prodrugs and uses thereof
|
AU2003297909A1
(en)
*
|
2002-12-11 |
2004-06-30 |
Xenoport, Inc. |
Orally administered dosage forms of fused gaba analog prodrugs having reduced toxicity
|
CN101797221B
(zh)
|
2002-12-13 |
2013-06-12 |
杜雷科特公司 |
包含高粘度液体载体材料的口服递药系统
|
US20080051411A1
(en)
*
|
2002-12-17 |
2008-02-28 |
Cink Russell D |
Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
|
WO2004054568A1
(en)
*
|
2002-12-17 |
2004-07-01 |
Abbott Gmbh & Co. Kg |
Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof
|
US7259186B2
(en)
*
|
2002-12-17 |
2007-08-21 |
Abbott Laboratories |
Salts of fenofibric acid and pharmaceutical formulations thereof
|
EP2339328A3
(en)
|
2002-12-30 |
2011-07-13 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical co-crystal compositions of celecoxib
|
US20050048099A1
(en)
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
KR20050095835A
(ko)
*
|
2003-01-14 |
2005-10-04 |
알자 코포레이션 |
조정된 점성층을 갖는 방법 및 제형
|
ATE401866T1
(de)
*
|
2003-02-11 |
2008-08-15 |
Alza Corp |
Verfahren und dosierformen mit modifizierter schichtgeometrie
|
ATE352394T1
(de)
*
|
2003-02-27 |
2007-02-15 |
Osmotica Corp |
Laserbohrsystem und -verfahren
|
EP1608357A4
(en)
*
|
2003-03-31 |
2008-03-26 |
Xenoport Inc |
TREATMENT OR PREVENTION OF HITZEWALLUNGEN USING PRODRUGS OF GABA ANALOGUE
|
TWI347201B
(en)
*
|
2003-04-21 |
2011-08-21 |
Euro Celtique Sa |
Pharmaceutical products,uses thereof and methods for preparing the same
|
US8029822B2
(en)
*
|
2003-05-22 |
2011-10-04 |
Osmotica Kereskedelmi és Seolgáltató KFT |
Rupturing controlled release device having a preformed passageway
|
US20060177507A1
(en)
*
|
2003-05-22 |
2006-08-10 |
Joaquina Faour |
Controlled release device containing lercanidipine
|
US20050058707A1
(en)
*
|
2003-08-06 |
2005-03-17 |
Iran Reyes |
Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
|
EP2354120A1
(en)
|
2003-08-20 |
2011-08-10 |
XenoPort, Inc. |
Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
|
WO2005019163A2
(en)
*
|
2003-08-20 |
2005-03-03 |
Xenoport, Inc. |
Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
|
JP2007503389A
(ja)
*
|
2003-08-22 |
2007-02-22 |
アルザ・コーポレーシヨン |
長期間にわたるトピラメートの段階的送達
|
CA2564227A1
(en)
*
|
2003-09-02 |
2005-03-10 |
Alza Corporation |
Novel drug compositions and dosage forms of topiramate
|
KR20060119971A
(ko)
*
|
2003-09-11 |
2006-11-24 |
제노포트 인코포레이티드 |
Gaba 유사체의 전구약물을 이용한 요실금의 치료및/또는 예방
|
CN1871021B
(zh)
*
|
2003-09-17 |
2010-07-28 |
什诺波特有限公司 |
用gaba类似物的前药治疗或预防多动腿综合征
|
EP2298303A1
(en)
|
2003-09-25 |
2011-03-23 |
Euro-Celtique S.A. |
Pharmaceutical combinations of hydrocodone and naltrexone
|
KR20060092255A
(ko)
*
|
2003-09-26 |
2006-08-22 |
알자 코포레이션 |
고도의 약물적재를 제공하는 약물코팅제 및 그의 제조방법
|
MXPA06003453A
(es)
*
|
2003-09-26 |
2006-08-31 |
Johnson & Johnson |
Barra de empuje oros para el suministro controlado de agentes activos.
|
AU2004275816A1
(en)
*
|
2003-09-26 |
2005-04-07 |
Alza Corporation |
Controlled release formulations of opioid and nonopioid analgesics
|
US20050088510A1
(en)
*
|
2003-10-24 |
2005-04-28 |
Shlomo Assa |
Low angle optics and reversed optics
|
US8987322B2
(en)
|
2003-11-04 |
2015-03-24 |
Circ Pharma Research And Development Limited |
Pharmaceutical formulations for carrier-mediated transport statins and uses thereof
|
US20050101582A1
(en)
*
|
2003-11-12 |
2005-05-12 |
Allergan, Inc. |
Compositions and methods for treating a posterior segment of an eye
|
US20070224278A1
(en)
*
|
2003-11-12 |
2007-09-27 |
Lyons Robert T |
Low immunogenicity corticosteroid compositions
|
US20060141049A1
(en)
*
|
2003-11-12 |
2006-06-29 |
Allergan, Inc. |
Triamcinolone compositions for intravitreal administration to treat ocular conditions
|
DK1691811T3
(da)
|
2003-12-11 |
2014-10-20 |
Sunovion Pharmaceuticals Inc |
Kombination af et sedativ og en neurotransmittermodulator og fremgangsmåder til forbedring af søvnkvaliteten og behandling af depression
|
US7046267B2
(en)
*
|
2003-12-19 |
2006-05-16 |
Markem Corporation |
Striping and clipping correction
|
AU2004308973A1
(en)
*
|
2003-12-23 |
2005-07-14 |
Alza Corporation |
Methods and dosage forms for increasing solubility of drug compositions for controlled delivery
|
EP1701706A2
(en)
*
|
2003-12-29 |
2006-09-20 |
Alza Corporation |
Novel drug compositions and dosage forms
|
CA2550699A1
(en)
*
|
2003-12-29 |
2005-07-21 |
Alza Corporation, Inc. |
Novel drug compositions and dosage forms of topiramate
|
US20050175696A1
(en)
*
|
2003-12-29 |
2005-08-11 |
David Edgren |
Drug granule coatings that impart smear resistance during mechanical compression
|
JP2007518804A
(ja)
|
2004-01-20 |
2007-07-12 |
アラーガン、インコーポレイテッド |
トリアムシノロンアセトニドおよびヒアルロン酸を好ましく含有する眼局所治療用組成物
|
TWI483944B
(zh)
*
|
2004-03-30 |
2015-05-11 |
Euro Celtique Sa |
含有小於25ppm14-羥可待因酮之羥可酮鹽酸鹽組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝
|
US7771742B2
(en)
|
2004-04-30 |
2010-08-10 |
Allergan, Inc. |
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
|
US20050244466A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Photodynamic therapy in conjunction with intraocular implants
|
US20070059336A1
(en)
*
|
2004-04-30 |
2007-03-15 |
Allergan, Inc. |
Anti-angiogenic sustained release intraocular implants and related methods
|
US20050244465A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Drug delivery systems and methods for treatment of an eye
|
US8425929B2
(en)
*
|
2004-04-30 |
2013-04-23 |
Allergan, Inc. |
Sustained release intraocular implants and methods for preventing retinal dysfunction
|
US20050244469A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
US20050244472A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Intraocular drug delivery systems containing excipients with reduced toxicity and related methods
|
BRPI0510485A
(pt)
|
2004-04-30 |
2007-11-13 |
Allergan Inc |
implantes inibidores de tirosina cinase intravìtreos biodegradáveis
|
US8722097B2
(en)
|
2004-04-30 |
2014-05-13 |
Allergan, Inc. |
Oil-in-water method for making polymeric implants containing a hypotensive lipid
|
US9498457B2
(en)
|
2004-04-30 |
2016-11-22 |
Allergan, Inc. |
Hypotensive prostamide-containing biodegradable intraocular implants and related implants
|
US7993634B2
(en)
|
2004-04-30 |
2011-08-09 |
Allergan, Inc. |
Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
|
US20050244478A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Anti-excititoxic sustained release intraocular implants and related methods
|
US7799336B2
(en)
|
2004-04-30 |
2010-09-21 |
Allergan, Inc. |
Hypotensive lipid-containing biodegradable intraocular implants and related methods
|
US20050244461A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Controlled release drug delivery systems and methods for treatment of an eye
|
US8147865B2
(en)
|
2004-04-30 |
2012-04-03 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US20050244463A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular vasculopathies
|
US8119154B2
(en)
|
2004-04-30 |
2012-02-21 |
Allergan, Inc. |
Sustained release intraocular implants and related methods
|
US8673341B2
(en)
*
|
2004-04-30 |
2014-03-18 |
Allergan, Inc. |
Intraocular pressure reduction with intracameral bimatoprost implants
|
US20050244471A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Estradiol derivative and estratopone containing sustained release intraocular implants and related methods
|
US20050244458A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular neuropathies
|
US8455656B2
(en)
|
2004-04-30 |
2013-06-04 |
Allergan, Inc. |
Kinase inhibitors
|
US20050244462A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Devices and methods for treating a mammalian eye
|
US20050244500A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Intravitreal implants in conjuction with photodynamic therapy to improve vision
|
US20060185357A1
(en)
*
|
2004-05-07 |
2006-08-24 |
Kovacevich Ian D |
Independently drawing and tensioning lines with bi-directional rotary device having two spools
|
US20050255406A1
(en)
*
|
2004-05-11 |
2005-11-17 |
Shlomo Assa |
Marking on a thin film
|
DE102004023069A1
(de)
|
2004-05-11 |
2005-12-08 |
Bayer Healthcare Ag |
Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil
|
US20060009425A1
(en)
*
|
2004-05-28 |
2006-01-12 |
Leticia Delgado-Herrera |
Oral formulations of paricalcitol
|
EP1604667A1
(en)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioids for the treatment of the restless leg syndrome
|
EP1604666A1
(en)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
|
ES2653568T3
(es)
|
2004-06-12 |
2018-02-07 |
Collegium Pharmaceutical, Inc. |
Formulaciones de fármacos para la prevención del abuso
|
US20050276849A1
(en)
*
|
2004-06-15 |
2005-12-15 |
Nilobon Podhipleux |
Sustained release dosage forms
|
US7713550B2
(en)
*
|
2004-06-15 |
2010-05-11 |
Andrx Corporation |
Controlled release sodium valproate formulation
|
US20050276848A1
(en)
*
|
2004-06-15 |
2005-12-15 |
Nilobon Podhipleux |
Sustained release neutralized divalproex sodium
|
US20050287185A1
(en)
*
|
2004-06-23 |
2005-12-29 |
David Wong |
Extended release oxybutynin formulation
|
US20050287212A1
(en)
*
|
2004-06-28 |
2005-12-29 |
Liang-Chang Dong |
Oral delivery system comprising a drug/polymer complex
|
WO2006007323A2
(en)
*
|
2004-06-28 |
2006-01-19 |
Alza Corporation |
Dosage forms for low solubility and/or low dissolution rate free acid pharmaceutical agents
|
BRPI0513243B8
(pt)
*
|
2004-07-12 |
2021-05-25 |
Allergan Inc |
composições oftálmicas e respectivos usos
|
US20060128676A1
(en)
*
|
2004-07-13 |
2006-06-15 |
Pharmacofore, Inc. |
Compositions of nicotinic agonists and therapeutic agents and methods for treating or preventing diseases or pain
|
JP2008510000A
(ja)
*
|
2004-08-19 |
2008-04-03 |
アルザ・コーポレーシヨン |
制御放出性ナノ粒子有効薬剤配合物投与剤型品および方法
|
US8541026B2
(en)
*
|
2004-09-24 |
2013-09-24 |
Abbvie Inc. |
Sustained release formulations of opioid and nonopioid analgesics
|
WO2006043965A1
(en)
*
|
2004-10-14 |
2006-04-27 |
Allergan, Inc. |
Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
|
US7494985B2
(en)
*
|
2004-11-03 |
2009-02-24 |
Xenoport, Inc. |
Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use
|
WO2006050471A2
(en)
*
|
2004-11-03 |
2006-05-11 |
Xenoport, Inc. |
Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use
|
BRPI0517227B8
(pt)
*
|
2004-11-04 |
2021-05-25 |
Xenoport Inc |
comprimido oral de liberação prolongada do ácido 1-{[alfa-isobutanoiloxietoxi)carbonil]amino metil}-1-cicloexano acético, e, uso do comprimido
|
AR053986A1
(es)
|
2004-12-03 |
2007-05-30 |
Osmotica Pharmaceutical Argent |
Dispositivo osmotico que contiene amantadina y una sal osmotica
|
JP5704789B2
(ja)
*
|
2005-01-28 |
2015-04-22 |
ユーロ−セルティーク エス.エイ. |
耐アルコール性剤形
|
EP1702558A1
(en)
|
2005-02-28 |
2006-09-20 |
Euro-Celtique S.A. |
Method and device for the assessment of bowel function
|
EP1695700A1
(en)
*
|
2005-02-28 |
2006-08-30 |
Euro-Celtique S.A. |
Dosage form containing oxycodone and naloxone
|
US7394479B2
(en)
|
2005-03-02 |
2008-07-01 |
Marken Corporation |
Pulsed laser printing
|
US20080152714A1
(en)
*
|
2005-04-08 |
2008-06-26 |
Yi Gao |
Pharmaceutical Formulations
|
UA100966C2
(ru)
|
2005-04-08 |
2013-02-25 |
Эбботт Леборетриз |
Фармацевтическая композиция на основе 2-[4-(4-хлорбензоил)фенокси]-2-метилпропионовой кислоты и ее солей
|
US20060229261A1
(en)
*
|
2005-04-12 |
2006-10-12 |
John Devane |
Acarbose methods and formulations for treating chronic constipation
|
CN101253148B
(zh)
|
2005-06-20 |
2013-01-02 |
克塞诺波特公司 |
凝血酸的酰氧基烷基氨基甲酸酯前药,合成和使用的方法
|
RU2408368C2
(ru)
|
2005-06-27 |
2011-01-10 |
Биовэйл Лэборэториз Интернэшнл С.Р.Л. |
Препараты соли бупропиона с модифицированным высвобождением
|
US20070003624A1
(en)
*
|
2005-06-29 |
2007-01-04 |
Shanbhag Anant R |
Semi-permeable compositions providing reduced drying time for osmotic dosage forms
|
ES2296454B1
(es)
*
|
2005-07-06 |
2009-05-05 |
Osmotica Corp. |
Sistema y metodo de perforacion laser.
|
TWI279234B
(en)
*
|
2005-07-12 |
2007-04-21 |
Anchen Pharmaceuticals Taiwan |
Method for controlling lag time of in-situ passageway formation in osmotic delivery system
|
EP1912622A2
(en)
*
|
2005-08-04 |
2008-04-23 |
Alza Corporation |
Osmotic dosage forms comprising semipermeable membranes with polymer blends providing improved properties
|
EP1928450A2
(en)
*
|
2005-08-26 |
2008-06-11 |
Xenoport, Inc. |
Treating premature ejaculation using gabapentin and pregabalin prodrugs
|
US7846445B2
(en)
*
|
2005-09-27 |
2010-12-07 |
Amunix Operating, Inc. |
Methods for production of unstructured recombinant polymers and uses thereof
|
WO2007038619A2
(en)
*
|
2005-09-27 |
2007-04-05 |
Amunix, Inc. |
Proteinaceous pharmaceuticals and uses thereof
|
US7855279B2
(en)
*
|
2005-09-27 |
2010-12-21 |
Amunix Operating, Inc. |
Unstructured recombinant polymers and uses thereof
|
US20090099031A1
(en)
*
|
2005-09-27 |
2009-04-16 |
Stemmer Willem P |
Genetic package and uses thereof
|
US20070190137A1
(en)
*
|
2005-10-07 |
2007-08-16 |
Reyes Iran |
Osmotic dosage form with controlled release and fast release aspects
|
PL116330U1
(en)
*
|
2005-10-31 |
2007-04-02 |
Alza Corp |
Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
|
EP1981525B1
(en)
|
2005-12-30 |
2015-01-21 |
Zensun (Shanghai) Science and Technology Limited |
Extended release of neuregulin for improved cardiac function
|
WO2007081736A1
(en)
*
|
2006-01-06 |
2007-07-19 |
Alza Corporation |
Osmotic dosage form with controlled release and fast release aspects
|
US20090022798A1
(en)
*
|
2007-07-20 |
2009-01-22 |
Abbott Gmbh & Co. Kg |
Formulations of nonopioid and confined opioid analgesics
|
US20090317355A1
(en)
*
|
2006-01-21 |
2009-12-24 |
Abbott Gmbh & Co. Kg, |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
US20100172989A1
(en)
*
|
2006-01-21 |
2010-07-08 |
Abbott Laboratories |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
EP1813276A1
(en)
*
|
2006-01-27 |
2007-08-01 |
Euro-Celtique S.A. |
Tamper resistant dosage forms
|
US20070178138A1
(en)
*
|
2006-02-01 |
2007-08-02 |
Allergan, Inc. |
Biodegradable non-opthalmic implants and related methods
|
US20070196487A1
(en)
*
|
2006-02-16 |
2007-08-23 |
Geerke Johan H |
Method and apparatus for drilling orifices in osmotic tablets incorporating near-infrared spectroscopy
|
WO2007106349A2
(en)
|
2006-03-10 |
2007-09-20 |
Neurogen Corporation |
Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues
|
EP2402037B8
(en)
|
2006-05-26 |
2019-12-04 |
Signature Therapeutics, Inc. |
Controlled release of phenolic opioids
|
US8158156B2
(en)
*
|
2006-06-19 |
2012-04-17 |
Alpharma Pharmaceuticals, Llc |
Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist
|
US8802128B2
(en)
*
|
2006-06-23 |
2014-08-12 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US20070298073A1
(en)
*
|
2006-06-23 |
2007-12-27 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
AU2007275033A1
(en)
*
|
2006-07-21 |
2008-01-24 |
Lab International Srl |
Hydrophobic abuse deterrent delivery system
|
CN100396278C
(zh)
*
|
2006-07-24 |
2008-06-25 |
冯莉萍 |
药用微丸丸芯及制备方法
|
CA2659037A1
(en)
*
|
2006-08-04 |
2008-03-13 |
Agi Therapeutics Research Limited |
Methods for treating at least one condition having mt1 receptor, 5ht2b receptor, and l-type calcium channel activity
|
US7585996B2
(en)
*
|
2006-09-15 |
2009-09-08 |
Xenoport, Inc. |
Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
|
MX2009005478A
(es)
|
2006-11-27 |
2009-08-12 |
Lundbeck & Co As H |
Derivados de heteroarilamida.
|
US8969415B2
(en)
|
2006-12-01 |
2015-03-03 |
Allergan, Inc. |
Intraocular drug delivery systems
|
WO2008073576A1
(en)
*
|
2006-12-08 |
2008-06-19 |
Alcon, Inc. |
Drug delivery device
|
MX2009006080A
(es)
*
|
2006-12-08 |
2009-07-14 |
Xenoport Inc |
Uso de profarmacos de analogos de gaba para el tratamiento de enfermedades.
|
GB0624880D0
(en)
*
|
2006-12-14 |
2007-01-24 |
Johnson Matthey Plc |
Improved method for making analgesics
|
US20090011018A1
(en)
*
|
2006-12-28 |
2009-01-08 |
Astellas Pharma Inc., |
Sustained release formulation for tacrolimus
|
US8524749B2
(en)
*
|
2007-02-09 |
2013-09-03 |
Alza Corporation |
Controlled release compositions of tizanidine
|
US7911053B2
(en)
*
|
2007-04-19 |
2011-03-22 |
Marvell World Trade Ltd. |
Semiconductor packaging with internal wiring bus
|
AU2008287340A1
(en)
*
|
2007-08-15 |
2009-02-19 |
Amunix, Inc. |
Compositions and methods for modifying properties of biologically active polypeptides
|
WO2009027852A2
(en)
*
|
2007-08-28 |
2009-03-05 |
Agi Therapeutics, P.L.C. |
Methods and compositions for treating gastrointestinal conditions
|
AU2008347158B8
(en)
|
2007-12-06 |
2013-08-22 |
Durect Corporation |
Oral pharmaceutical dosage forms
|
US8623418B2
(en)
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
US20100151014A1
(en)
*
|
2008-12-16 |
2010-06-17 |
Alpharma Pharmaceuticals, Llc |
Pharmaceutical composition
|
JP2011511782A
(ja)
|
2008-02-12 |
2011-04-14 |
アボット・ラボラトリーズ |
長期放出性ヒドロコドンアセトアミノフェンならびにその関連方法および用途
|
CA2730211C
(en)
*
|
2008-07-07 |
2016-11-08 |
Euro-Celtique S.A. |
Use of opioid antagonists for treating urinary retention
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
CA2748314C
(en)
|
2009-02-03 |
2018-10-02 |
Amunix Operating Inc. |
Extended recombinant polypeptides and compositions comprising same
|
EP3045043B1
(en)
|
2009-02-26 |
2020-04-29 |
Relmada Therapeutics, Inc. |
Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use
|
EP2405915B1
(en)
|
2009-03-10 |
2018-10-24 |
Euro-Celtique S.A. |
Immediate release pharmaceutical compositions comprising oxycodone and naloxone
|
CA2764108A1
(en)
|
2009-06-08 |
2010-12-16 |
Amunix Operating Inc. |
Glucose-regulating polypeptides and methods of making and using same
|
ES2643641T3
(es)
|
2009-06-08 |
2017-11-23 |
Amunix Operating Inc. |
Polipéptidos de hormona del crecimiento y métodos de producción y uso de los mismos
|
WO2011028229A1
(en)
|
2009-08-24 |
2011-03-10 |
Amunix Operating Inc. |
Coagulation factor ix compositions and methods of making and using same
|
WO2011028234A1
(en)
*
|
2009-09-04 |
2011-03-10 |
Xenoport, Inc. |
Uses of acyloxyalkyl carbamate prodrugs of tranexamic acid
|
US20120322882A1
(en)
|
2009-11-09 |
2012-12-20 |
Allergan, Inc. |
Compositions And Methods For Stimulating Hair Growth
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
WO2011091164A1
(en)
*
|
2010-01-22 |
2011-07-28 |
Xenoport, Inc. |
Oral dosage forms having a high loading of a tranexamic acid prodrug
|
WO2011122524A1
(ja)
|
2010-03-29 |
2011-10-06 |
アステラス製薬株式会社 |
放出制御医薬組成物
|
CN107050456B
(zh)
|
2010-09-28 |
2022-08-12 |
加利福尼亚大学董事会 |
治疗代谢综合征相关疾病的gaba激动剂和治疗或预防i型糖尿病的gaba组合
|
MY166034A
(en)
|
2010-12-22 |
2018-05-21 |
Purdue Pharma Lp |
Encased tamper resistant controlled release dosage forms
|
JP5638151B2
(ja)
|
2010-12-23 |
2014-12-10 |
パーデュー、ファーマ、リミテッド、パートナーシップ |
不正加工抵抗性の(tamperresistant)固形経口剤形
|
DE102011007272A1
(de)
|
2011-04-13 |
2012-10-18 |
Bayer Pharma Aktiengesellschaft |
Verzweigte 3-Phenylpropionsäure-Derivate und ihre Verwendung
|
EP2755826B1
(en)
|
2011-09-16 |
2019-05-01 |
Tri-Star Technologies |
Laser capsule marking system and method
|
US20130143867A1
(en)
|
2011-12-02 |
2013-06-06 |
Sychroneuron Inc. |
Acamprosate formulations, methods of using the same, and combinations comprising the same
|
CN103202768B
(zh)
*
|
2012-01-11 |
2014-04-09 |
玄文明 |
一种药片盘式负压处理装置
|
CA2864126A1
(en)
|
2012-02-15 |
2013-08-22 |
Biogen Idec Ma Inc. |
Recombinant factor viii proteins
|
LT3564260T
(lt)
|
2012-02-15 |
2023-01-10 |
Bioverativ Therapeutics Inc. |
Viii faktoriaus kompozicijos ir jų gamybos bei panaudojimo būdai
|
CN104302280A
(zh)
|
2012-04-17 |
2015-01-21 |
普渡制药公司 |
用于治疗阿片样物质所致不良药效学响应的系统和方法
|
CN102699539B
(zh)
*
|
2012-06-14 |
2014-07-30 |
天津工业自动化仪表研究所有限公司 |
一种全功能渗透泵控释片激光打孔机
|
SG11201407988UA
(en)
|
2012-07-16 |
2015-01-29 |
Rhodes Technologies |
Process for improved opioid synthesis
|
AR091779A1
(es)
|
2012-07-16 |
2015-02-25 |
Rhodes Technologies |
Procedimiento para la sintesis mejorada de opioides
|
US10149390B2
(en)
*
|
2012-08-27 |
2018-12-04 |
Mycronic AB |
Maskless writing of a workpiece using a plurality of exposures having different focal planes using multiple DMDs
|
US9149533B2
(en)
|
2013-02-05 |
2015-10-06 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
EP2956096A1
(en)
|
2013-02-15 |
2015-12-23 |
Allergan, Inc. |
Sustained drug delivery implant
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
WO2014144975A1
(en)
|
2013-03-15 |
2014-09-18 |
Durect Corporation |
Compositions with a rheological modifier to reduce dissolution variability
|
JP2016521279A
(ja)
|
2013-04-30 |
2016-07-21 |
アッヴィ・インコーポレイテッド |
アトラセンタンを使用して脂質プロファイルを改善するための方法
|
CN105579037A
(zh)
|
2013-05-31 |
2016-05-11 |
武田制药美国有限公司 |
用黄嘌呤氧化酶抑制剂治疗的方法和含黄嘌呤氧化酶抑制剂的组合物
|
CN105431144A
(zh)
|
2013-06-05 |
2016-03-23 |
思康脑侒股份有限公司 |
阿坎酸制剂、使用阿坎酸制剂的方法以及包含阿坎酸制剂的组合
|
US20160120861A1
(en)
|
2013-06-28 |
2016-05-05 |
Purdue Pharma L.P. |
Compositions and Methods for Treating an Arrhythmia with an Opioid Antagonist
|
NZ716267A
(en)
|
2013-07-23 |
2017-05-26 |
Euro Celtique Sa |
A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
|
BR112016002079A2
(pt)
|
2013-08-02 |
2017-09-05 |
Johnson Matthey Plc |
Processo para preparação de um aditivo ácido de oximorfona, solução aquosa de aditivo ácido de oximorfona, aditivo ácido de oximorfona sólido, e, alcaloide de oximorfona sólido
|
TW202003554A
(zh)
|
2013-08-14 |
2020-01-16 |
美商百歐維拉提夫治療公司 |
因子viii-xten融合物及其用途
|
MX2016009300A
(es)
|
2014-01-15 |
2017-04-13 |
Rhodes Tech |
Proceso para la sintesis mejorada de oxicodona.
|
MX2016009125A
(es)
|
2014-01-15 |
2017-02-02 |
Rhodes Tech |
Proceso para la sintesis mejorada de oximorfona.
|
US9062063B1
(en)
|
2014-03-21 |
2015-06-23 |
Johnson Matthey Public Limited Company |
Forms of oxymorphone hydrochloride
|
CN105583531B
(zh)
*
|
2014-10-23 |
2017-08-22 |
大族激光科技产业集团股份有限公司 |
一种高速精准药片激光打孔机
|
JP2016097438A
(ja)
*
|
2014-11-26 |
2016-05-30 |
元成機械股▲ふん▼有限公司 |
レーザー穴あけシステム
|
US9918979B2
(en)
|
2015-01-29 |
2018-03-20 |
Johnson Matthey Public Limited Company |
Process of preparing low ABUK oxymorphone hydrochloride
|
BR112017017729A2
(pt)
|
2015-02-20 |
2018-04-10 |
Osmotica Kereskedelmi Es Szolgaltato Kft |
forma de dosagem oral de liberação controlada de agonista de receptor gaba
|
EA201890423A1
(ru)
|
2015-08-03 |
2018-07-31 |
Биовератив Терапьютикс Инк. |
Слитые белки фактора ix, способы их получения и применения
|
WO2017059459A1
(en)
|
2015-10-01 |
2017-04-06 |
Elysium Therapeutics, Inc. |
Polysubunit opioid prodrugs resistant to overdose and abuse
|
US10335406B2
(en)
|
2015-10-01 |
2019-07-02 |
Elysium Therapeutics, Inc. |
Opioid compositions resistant to overdose and abuse
|
US20170296471A1
(en)
*
|
2016-04-13 |
2017-10-19 |
Scantech Laser Pvt. Ltd. |
Unique high speed tablet drilling laser system
|
WO2017222575A1
(en)
|
2016-06-23 |
2017-12-28 |
Collegium Pharmaceutical, Inc. |
Process of making more stable abuse-deterrent oral formulations
|
EP3595663A4
(en)
|
2017-03-17 |
2021-01-13 |
Elysium Therapeutics, Inc. |
MULTI-UNIT OPIOID MEDICINES RESISTANT TO OVERDOSE AND ABUSE
|
CN109434297A
(zh)
*
|
2017-06-07 |
2019-03-08 |
合肥智慧龙图腾知识产权股份有限公司 |
一种微调型激光切割装置
|
MX2020008527A
(es)
|
2018-02-16 |
2020-09-18 |
Esperion Therapeutics Inc |
Formulaciones de liberacion sostenida de acido bempedoico.
|
SG11202010767SA
(en)
|
2018-05-18 |
2020-11-27 |
Bioverativ Therapeutics Inc |
Methods of treating hemophilia a
|
US10905667B2
(en)
|
2018-07-24 |
2021-02-02 |
Bayer Pharma Aktiengesellschaft |
Orally administrable modified-release pharmaceutical dosage form
|
WO2020020790A1
(de)
|
2018-07-24 |
2020-01-30 |
Bayer Aktiengesellschaft |
Oral applizierbare pharmazeutische darreichungsform mit modifizierter freisetzung
|
EP3826627B1
(de)
|
2018-07-24 |
2023-10-18 |
Bayer Aktiengesellschaft |
Oral applizierbare pharmazeutische darreichungsform mit modifizierter freisetzung
|
US10583668B2
(en)
|
2018-08-07 |
2020-03-10 |
Markem-Imaje Corporation |
Symbol grouping and striping for wide field matrix laser marking
|
CN110181183A
(zh)
*
|
2019-07-08 |
2019-08-30 |
深圳市大鹏激光科技有限公司 |
一种光纤激光切割机
|
WO2021029020A1
(ja)
|
2019-08-13 |
2021-02-18 |
大塚製薬株式会社 |
経口医薬組成物
|
PT4153136T
(pt)
|
2020-06-10 |
2024-03-22 |
Auspex Pharmaceuticals Inc |
Formas de dosagem osmótica que compreendem deutetrabenazina e métodos de utilização da mesma
|
WO2023240186A1
(en)
|
2022-06-08 |
2023-12-14 |
Auspex Pharmaceuticals, Inc. |
Osmotic dosage forms comprising deutetrabenazine and methods of use thereof
|